This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Standaert, M. L. Articles by Farese, R. V. Search for Related Content PubMed PubMed Citation Articles by Standaert, M. L. Articles by Farese, R. V.

RO 31-8220 Activates c-Jun N-Terminal Kinase and Glycogen Synthase in Rat Adipocytes and L6 Myotubes. Comparison to Actions of Insulin¹

J. A. Haley Veteran’s Hospital Research Service, and Departments of Internal Medicine and Biochemistry/Molecular Biology, University of South Florida College of Medicine, Tampa, Florida 33612

Address all correspondence and requests for reprints to: Robert V. Farese, M.D., Research Service (VAR 151), J. A. Haley VA Hospital, 13000 Bruce B. Downs Boulevard, Tampa, Florida 33612.

The activation of c-Jun N-terminal kinase (JNK) by insulin and anisomycin has been reported to result in increases in glycogen synthase (GS) activity in rat skeletal muscle (Moxham et al., J Biol Chem, 1996, 271:30765-30773). In addition, the protein kinase C (PKC) inhibitor, RO 31-8220, has been reported to activate JNK in rat-1 fibroblasts (Beltman et al., J Biol Chem, 1996, 271:27018-27024). Presently, we found that the RO 31-8220, as well as insulin, activated JNK and GS and stimulated glucose incorporation into glycogen in rat adipocytes and L6 myotubes. In contrast to activation of JNK, RO 31-8220 inhibited extracellular response kinases 1 and 2 (ERK1/2) and had no significant effects on protein kinase B (PKB). Stimulatory effects of RO 31-8220 on JNK and glycogen metabolism were not explained by PKC inhibition, as other PKC inhibitors were without effect on glucose incorporation into glycogen and have no effect on JNK (Beltman et al., J Biol Chem, 1996, 271:27018). Insulin, on the other hand, activated JNK, as well as PKB and ERK1/2. However, stimulatory effects of insulin on GS and glucose incorporation into glycogen appeared to be fully intact and additive to those of RO 31-8220, despite the fact that insulin did not provoke additive increases in JNK activity above those observed with RO 31-8220 alone. Our findings suggest that JNK serves to activate GS during the action of RO 31-8220 in rat adipocytes and L6 myotubes; insulin, on the other hand, appears to activate GS largely independently of JNK.

This article has been cited by other articles:

				B. H. Shah, J. A. Olivares-Reyes, and K. J. Catt The Protein Kinase C Inhibitor Go6976 [12-(2-Cyanoethyl)-6,7,12,13-tetrahydro-13-methyl-5-oxo-5H-indolo(2,3-a)pyrrolo(3,4-c)-carbazole] Potentiates Agonist-Induced Mitogen-Activated Protein Kinase Activation through Tyrosine Phosphorylation of the Epidermal Growth Factor Receptor Mol. Pharmacol., January 1, 2005; 67(1): 184 - 194. [Abstract] [Full Text] [PDF]

				N. Fujii, M. D. Boppart, S. D. Dufresne, P. F. Crowley, A. C. Jozsi, K. Sakamoto, H. Yu, W. G. Aschenbach, S. Kim, H. Miyazaki, et al. Overexpression or ablation of JNK in skeletal muscle has no effect on glycogen synthase activity Am J Physiol Cell Physiol, July 1, 2004; 287(1): C200 - C208. [Abstract] [Full Text] [PDF]

				Y. H. Lee, J. Giraud, R. J. Davis, and M. F. White c-Jun N-terminal Kinase (JNK) Mediates Feedback Inhibition of the Insulin Signaling Cascade J. Biol. Chem., January 24, 2003; 278(5): 2896 - 2902. [Abstract] [Full Text] [PDF]

				R. Cazzolli, D. L. Craig, T. J. Biden, and C. Schmitz-Peiffer Inhibition of glycogen synthesis by fatty acid in C2C12 muscle cells is independent of PKC-alpha , -epsilon , and -theta Am J Physiol Endocrinol Metab, June 1, 2002; 282(6): E1204 - E1213. [Abstract] [Full Text] [PDF]

				R. V. Farese Insulin-Sensitive Phospholipid Signaling Systems and Glucose Transport. Update II Experimental Biology and Medicine, April 1, 2001; 226(4): 283 - 295. [Abstract] [Full Text]

				S. Nemoto, K. Takeda, Z.-X. Yu, V. J. Ferrans, and T. Finkel Role for Mitochondrial Oxidants as Regulators of Cellular Metabolism Mol. Cell. Biol., October 1, 2000; 20(19): 7311 - 7318. [Abstract] [Full Text]

				C. E. Chalfant, T. P. Ciaraldi, J. E. Watson, S. Nikoulina, R. R. Henry, and D. R. Cooper Protein Kinase C{theta} Expression Is Increased upon Differentiation of Human Skeletal Muscle Cells: Dysregulation in Type 2 Diabetic Patients and a Possible Role for Protein Kinase C{theta} in Insulin-Stimulated Glycogen Synthase Activity Endocrinology, August 1, 2000; 141(8): 2773 - 2778. [Abstract] [Full Text] [PDF]

				K. Fukunaga, T. Noguchi, H. Takeda, T. Matozaki, Y. Hayashi, H. Itoh, and M. Kasuga Requirement for Protein-tyrosine Phosphatase SHP-2 in Insulin-induced Activation of c-Jun NH2-terminal Kinase J. Biol. Chem., February 18, 2000; 275(7): 5208 - 5213. [Abstract] [Full Text] [PDF]

				S. Monno, M. V. Newman, M. Cook, and W. L. Lowe Jr. Insulin-Like Growth Factor I Activates c-Jun N-Terminal Kinase in MCF-7 Breast Cancer Cells Endocrinology, February 1, 2000; 141(2): 544 - 550. [Abstract] [Full Text] [PDF]

				L. Song, P. De Sarno, and R. S. Jope Muscarinic Receptor Stimulation Increases Regulators of G-protein Signaling 2 mRNA Levels through a Protein Kinase C-dependent Mechanism J. Biol. Chem., October 15, 1999; 274(42): 29689 - 29693. [Abstract] [Full Text] [PDF]

				G. Bandyopadhyay, M. L. Standaert, M. P. Sajan, L. M. Karnitz, L. Cong, M. J. Quon, and R. V. Farese Dependence of Insulin-Stimulated Glucose Transporter 4 Translocation on 3-Phosphoinositide-Dependent Protein Kinase-1 and Its Target Threonine-410 in the Activation Loop of Protein Kinase C-{zeta} Mol. Endocrinol., October 1, 1999; 13(10): 1766 - 1772. [Abstract] [Full Text]